Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TracInnovations is a Danish medical technology company focused on improving image-based diagnosis through markerless motion tracking for MRI and related imaging workflows. Its core commercial product is the Tracoline/TCL3 motion tracking system, a 3D stereo-vision device that monitors patient head movement in real time during brain scans to reduce motion artifacts and improve image quality. The company markets its solution for use in clinical MRI environments, particularly where patient motion can lead to rescans, sedation, or non-diagnostic studies, such as in pediatric and motion-impaired populations. TracInnovations states that its motion tracking products are FDA-cleared and CE-marked, while some motion-correction capabilities remain research-use-only. The business appears to operate as a venture-backed private medtech company selling imaging workflow and diagnostic-quality enhancement solutions to hospitals, imaging centers, and research users.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TracInnovations.